Primary sterile necrotic cells fail to cross-prime CD8⁺ T cells

References

• Ma Y, Conforti R, Aymeric L, Locher C, Kepp O, Kroemer G, et al. How to improve the immunogenicity of chemotherapy and radiotherapy. Cancer Metastasis Rev 2011; 30:71 - 82; http://dx.doi.org/10.1007/s10555-011-9283-2; PMID: 21298323
   PubMed Web of Science ®Google Scholar
• Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5:1249 - 55; http://dx.doi.org/10.1038/15200; PMID: 10545990
   PubMed Web of Science ®Google Scholar
• Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12:991 - 1045; http://dx.doi.org/10.1146/annurev.iy.12.040194.005015; PMID: 8011301
   PubMed Web of Science ®Google Scholar
• Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191:423 - 34; http://dx.doi.org/10.1084/jem.191.3.423; PMID: 10662788
   PubMed Web of Science ®Google Scholar
• Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 2000; 12:1539 - 46; http://dx.doi.org/10.1093/intimm/12.11.1539; PMID: 11058573
   PubMed Web of Science ®Google Scholar
• Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418:191 - 5; http://dx.doi.org/10.1038/nature00858; PMID: 12110890
   PubMed Web of Science ®Google Scholar
• Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425:516 - 21; http://dx.doi.org/10.1038/nature01991; PMID: 14520412
   PubMed Web of Science ®Google Scholar
• Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, Matoba H, et al. Genomic DNA released by dying cells induces the maturation of APCs. J Immunol 2001; 167:2602 - 7; PMID: 11509601
   PubMed Web of Science ®Google Scholar
• Karikó K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279:12542 - 50; http://dx.doi.org/10.1074/jbc.M310175200; PMID: 14729660
   PubMed Web of Science ®Google Scholar
• Lee J, Chuang TH, Redecke V, She L, Pitha PM, Carson DA, et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci U S A 2003; 100:6646 - 51; http://dx.doi.org/10.1073/pnas.0631696100; PMID: 12738885
   PubMed Web of Science ®Google Scholar
• Wilkin F, Duhant X, Bruyns C, Suarez-Huerta N, Boeynaems JM, Robaye B. The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J Immunol 2001; 166:7172 - 7; PMID: 11390464
   PubMed Web of Science ®Google Scholar
• Ahrens S, Zelenay S, Sancho D, Hanč P, Kjær S, Feest C, et al. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 2012; 36:635 - 45; http://dx.doi.org/10.1016/j.immuni.2012.03.008; PMID: 22483800
   PubMed Web of Science ®Google Scholar
• Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005; 11:1173 - 9; http://dx.doi.org/10.1038/nm1315; PMID: 16244651
   PubMed Web of Science ®Google Scholar
• Woo M, Hakem R, Mak TW. Executionary pathway for apoptosis: lessons from mutant mice. Cell Res 2000; 10:267 - 78; http://dx.doi.org/10.1038/sj.cr.7290054; PMID: 11191349
   PubMed Web of Science ®Google Scholar
• Joza N, Kroemer G, Penninger JM. Genetic analysis of the mammalian cell death machinery. Trends Genet 2002; 18:142 - 9; http://dx.doi.org/10.1016/S0168-9525(01)02618-X; PMID: 11858838
   PubMed Web of Science ®Google Scholar
• Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, Steinman RM. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002; 196:1091 - 7; http://dx.doi.org/10.1084/jem.20021215; PMID: 12391020
   PubMed Web of Science ®Google Scholar
• Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392:86 - 9; http://dx.doi.org/10.1038/32183; PMID: 9510252
   PubMed Web of Science ®Google Scholar
• Nowak AK, Lake RA, Marzo AL, Scott B, Heath WR, Collins EJ, et al. Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J Immunol 2003; 170:4905 - 13; PMID: 12734333
   PubMed Web of Science ®Google Scholar
• Janssen E, Tabeta K, Barnes MJ, Rutschmann S, McBride S, Bahjat KS, et al. Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. Immunity 2006; 24:787 - 99; http://dx.doi.org/10.1016/j.immuni.2006.03.024; PMID: 16782034
   PubMed Web of Science ®Google Scholar
• Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 2005; 202:1691 - 701; http://dx.doi.org/10.1084/jem.20050915; PMID: 16365148
   PubMed Web of Science ®Google Scholar
• Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15:1170 - 8; http://dx.doi.org/10.1038/nm.2028; PMID: 19767732
   PubMed Web of Science ®Google Scholar
• Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13:54 - 61; http://dx.doi.org/10.1038/nm1523; PMID: 17187072
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011; 147:728 - 41; http://dx.doi.org/10.1016/j.cell.2011.10.026; PMID: 22078875
   PubMed Web of Science ®Google Scholar
• Uhl M, Kepp O, Jusforgues-Saklani H, Vicencio JM, Kroemer G, Albert ML. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells. Cell Death Differ 2009; 16:991 - 1005; http://dx.doi.org/10.1038/cdd.2009.8; PMID: 19229247
   PubMed Web of Science ®Google Scholar
• Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011; 334:1573 - 7; http://dx.doi.org/10.1126/science.1208347; PMID: 22174255
   PubMed Web of Science ®Google Scholar
• Hirt UA, Leist M. Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ 2003; 10:1156 - 64; http://dx.doi.org/10.1038/sj.cdd.4401286; PMID: 14502239
   PubMed Web of Science ®Google Scholar
• Brouckaert G, Kalai M, Krysko DV, Saelens X, Vercammen D, Ndlovu MN, et al. Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol Biol Cell 2004; 15:1089 - 100; http://dx.doi.org/10.1091/mbc.E03-09-0668; PMID: 14668480
   PubMed Web of Science ®Google Scholar
• Scheffer SR, Nave H, Korangy F, Schlote K, Pabst R, Jaffee EM, et al. Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int J Cancer 2003; 103:205 - 11; http://dx.doi.org/10.1002/ijc.10777; PMID: 12455034
   PubMed Web of Science ®Google Scholar
• Gamrekelashvili J, Krüger C, von Wasielewski R, Hoffmann M, Huster KM, Busch DH, et al. Necrotic tumor cell death in vivo impairs tumor-specific immune responses. J Immunol 2007; 178:1573 - 80; PMID: 17237406
   PubMed Web of Science ®Google Scholar
• Somersan S, Larsson M, Fonteneau JF, Basu S, Srivastava P, Bhardwaj N. Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J Immunol 2001; 167:4844 - 52; PMID: 11673488
   PubMed Web of Science ®Google Scholar
• Salio M, Cerundolo V, Lanzavecchia A. Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells. Eur J Immunol 2000; 30:705 - 8; http://dx.doi.org/10.1002/1521-4141(200002)30:2<705::AID-IMMU705>3.0.CO;2-P; PMID: 10671230
   PubMed Web of Science ®Google Scholar
• Singh-Jasuja H, Scherer HU, Hilf N, Arnold-Schild D, Rammensee HG, Toes RE, et al. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 2000; 30:2211 - 5; PMID: 10940912
   PubMed Web of Science ®Google Scholar
• Vabulas RM, Braedel S, Hilf N, Singh-Jasuja H, Herter S, Ahmad-Nejad P, et al. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem 2002; 277:20847 - 53; http://dx.doi.org/10.1074/jbc.M200425200; PMID: 11912201
   PubMed Web of Science ®Google Scholar
• Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 2002; 277:15107 - 12; http://dx.doi.org/10.1074/jbc.M111204200; PMID: 11842086
   PubMed Web of Science ®Google Scholar
• Shi Y, Zheng W, Rock KL. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc Natl Acad Sci U S A 2000; 97:14590 - 5; http://dx.doi.org/10.1073/pnas.260497597; PMID: 11106387
   PubMed Web of Science ®Google Scholar
• Sancho D, Joffre OP, Keller AM, Rogers NC, Martínez D, Hernanz-Falcón P, et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009; 458:899 - 903; http://dx.doi.org/10.1038/nature07750; PMID: 19219027
   PubMed Web of Science ®Google Scholar
• Blakey DC, Westwood FR, Walker M, Hughes GD, Davis PD, Ashton SE, et al. Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. Clin Cancer Res 2002; 8:1974 - 83; PMID: 12060643
   PubMed Web of Science ®Google Scholar
• den Brok MH, Sutmuller RP, Nierkens S, Bennink EJ, Frielink C, Toonen LW, et al. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br J Cancer 2006; 95:896 - 905; http://dx.doi.org/10.1038/sj.bjc.6603341; PMID: 16953240
   PubMed Web of Science ®Google Scholar
• den Brok MH, Sutmuller RP, Nierkens S, Bennink EJ, Toonen LW, Figdor CG, et al. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine. Cancer Res 2006; 66:7285 - 92; http://dx.doi.org/10.1158/0008-5472.CAN-06-0206; PMID: 16849578
   PubMed Web of Science ®Google Scholar
• Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, Berglund P, et al. CD8+ T cell cross-priming via transfer of proteasome substrates. Science 2004; 304:1318 - 21; http://dx.doi.org/10.1126/science.1096378; PMID: 15166379
   PubMed Web of Science ®Google Scholar
• Lev A, Takeda K, Zanker D, Maynard JC, Dimberu P, Waffarn E, et al. The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. Immunity 2008; 28:787 - 98; http://dx.doi.org/10.1016/j.immuni.2008.04.015; PMID: 18549799
   PubMed Web of Science ®Google Scholar
• Kurts C, Miller JF, Subramaniam RM, Carbone FR, Heath WR. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med 1998; 188:409 - 14; http://dx.doi.org/10.1084/jem.188.2.409; PMID: 9670054
   PubMed Web of Science ®Google Scholar
• Heath WR, Carbone FR. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 2001; 19:47 - 64; http://dx.doi.org/10.1146/annurev.immunol.19.1.47; PMID: 11244030
   PubMed Web of Science ®Google Scholar
• Li M, Davey GM, Sutherland RM, Kurts C, Lew AM, Hirst C, et al. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol 2001; 166:6099 - 103; PMID: 11342628
   PubMed Web of Science ®Google Scholar
• Yewdell JW. The seven dirty little secrets of major histocompatibility complex class I antigen processing. Immunol Rev 2005; 207:8 - 18; http://dx.doi.org/10.1111/j.0105-2896.2005.00309.x; PMID: 16181323
   PubMed Web of Science ®Google Scholar
• de Brito C, Tomkowiak M, Ghittoni R, Caux C, Leverrier Y, Marvel J. CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected]. [corrected] J Immunol 2011; 186:1503 - 11; http://dx.doi.org/10.4049/jimmunol.1001022; PMID: 21187449
   PubMed Web of Science ®Google Scholar
• Silagi S. Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance. J Cell Biol 1969; 43:263 - 74; http://dx.doi.org/10.1083/jcb.43.2.263; PMID: 4981070
   PubMed Web of Science ®Google Scholar
• Klein C, Bueler H, Mulligan RC. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. J Exp Med 2000; 191:1699 - 708; http://dx.doi.org/10.1084/jem.191.10.1699; PMID: 10811863
   PubMed Web of Science ®Google Scholar
• Clarke SR, Barnden M, Kurts C, Carbone FR, Miller JF, Heath WR. Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol 2000; 78:110 - 7; http://dx.doi.org/10.1046/j.1440-1711.2000.00889.x; PMID: 10762410
   PubMed Web of Science ®Google Scholar
• Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76:17 - 27; http://dx.doi.org/10.1016/0092-8674(94)90169-4; PMID: 8287475
   PubMed Web of Science ®Google Scholar
• Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740 - 5; http://dx.doi.org/10.1038/35047123; PMID: 11130078
   PubMed Web of Science ®Google Scholar
• Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162:3749 - 52; PMID: 10201887
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11:443 - 51; http://dx.doi.org/10.1016/S1074-7613(00)80119-3; PMID: 10549626
   PubMed Web of Science ®Google Scholar
• Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998; 9:143 - 50; http://dx.doi.org/10.1016/S1074-7613(00)80596-8; PMID: 9697844
   PubMed Web of Science ®Google Scholar
• Spiller S, Dreher S, Meng G, Grabiec A, Thomas W, Hartung T, et al. Cellular recognition of trimyristoylated peptide or enterobacterial lipopolysaccharide via both TLR2 and TLR4. J Biol Chem 2007; 282:13190 - 8; http://dx.doi.org/10.1074/jbc.M610340200; PMID: 17353199
   PubMed Web of Science ®Google Scholar
• Oehen S, Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J Immunol 1998; 161:5338 - 46; PMID: 9820507
   PubMed Web of Science ®Google Scholar